Loading chat...

HI HB661

Bill

Status

Introduced

1/23/2017

Primary Sponsor

Marcus Oshiro

Click for details

Origin

House of Representatives

2018 Regular Session

AI Summary

  • Limits tetrahydrocannabinol (THC) potency in manufactured marijuana products to no more than 12 percent.

  • Requires warning labels on packaging of manufactured marijuana products stating "WARNING: THE HEALTH IMPACTS OF MARIJUANA WITH THC POTENCY LEVELS OF 10 PERCENT AND OVER ARE UNKNOWN" in bold capital letters at least 14-point font.

  • Maintains existing requirement that capsules, lozenges, or pills contain no more than 10 milligrams of THC per dose and no more than 100 milligrams total per container.

  • Addresses concerns raised by a task force minority regarding adolescent brain development, fetal exposure, marijuana-impaired driving, and unregulated product potency and dosage information.

Legislative Description

Relating To Medical Marijuana.

Medical Marijuana

Last Action

Re-referred to HHS, FIN, referral sheet 1

1/17/2018

Committee Referrals

Health & Human Services1/17/2018
Health1/25/2017

Full Bill Text

No bill text available